|
|
||||
|
Can sequences turn a profit?
Email: Tabitha M Powledge - tam@nasw.org News from The Scientist 2002, 3(1):20020516-03
|
||||
|
|
||||
|
MARYLAND — Michael C. Nehls calls it "a breakthrough that is already changing how we will elucidate novel biology in order to advance medicine." He is just one among thousands of biomedical researchers who expect to profit from the public release of the draft mouse genome sequence last week.
|
|
|||||||||
|
|||||||||
|